C Peptide, Serum
Test Code: 1141 | CPT Code: 84681 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: C-peptide is useful in the evaluation of pancreatic function since it gives a direct evaluation of beta cell function. |
|
Run Day: Sun, Tue, Thurs | |
Reporting Day: Next day |
C Reactive Protein (CRP), Quantitative, Serum
Test Code: 339 | CPT Code: 86140 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Grosshemolysis and lipemic | |
Methodology: Immunoturbidometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Increased CRP levels are found in inflammatory conditions including bacterial infections, rheumatic fever, active arthritis, myocardial infarction, malignancies and in the post-operative state. This test cannot detect |
|
Run Day: Daily | |
Reporting Day: Same day |
C. Diphtheria, Albert Staining
Test Code: 391 | CPT Code: 88312 |
Specimen Type: Throat Swab | |
Sample Volume: Swab in aerobic transport medium | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Expired transport device, frozen, dry swabs | |
Methodology: Microscopic | |
Special Requirements: No special precautions needed | |
Clinical Significance: Helps in presumptive identification of Corynebacterium species in clinical specimens. Diphtheria culture should also be performed in suspected cases |
|
Run Day: Daily | |
Reporting Day: Next day |
C1 Esterase Inhibitor, Functional Assay, Serum
Test Code: 6916 | CPT Code: 83520 |
Specimen Type: Serum (red-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Serum in gel tube (yellow-top) | |
Methodology: Enzyme immunoassay | |
Special Requirements: Immediately after drawing the specimen, place the tube on wet ice. Centrifuge and separate serum. Freeze specimen within 30 min | |
Clinical Significance: C1 inhibitor (C1-INH) is a multispecific protease inhibitor that regulates enzymes of the complement, coagulation, fibrinolytic, and kinin systems. A deficiency of functionally active C1-INH may lead to life-threatening angioedema. Two major forms of C1-INH deficiency are known; the congenital form hereditary angioedema (HAE), and the acquired form that is associated with a variety of conditions, including lymphoid malignancies. C1-INH functional assay is useful in diagnosis of hereditary angioedema and for monitoring response to therapy. |
|
Run Day: 2nd and 4th Mon | |
Reporting Day: Same day |
C1 Esterase Inhibitor, Serum
Test Code: 340 | CPT Code: 86160 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: Immunoturbidometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: The C1 esterase inhibitor protein is a normal constituent of serum which functions as a serine proteinase inhibitor of the serpin family. The C1 esterase inhibitor inhibits the complement proteases C1r and C1s, as well as the proteases kallikrein, factor XIa, XIIa and plasmin of the blood clotting system. The concentration of |
|
Run Day: Mon: 2nd & 4th | |
Reporting Day: 2nd day of run |
Calcitonin, Serum
Test Code: 6153 | CPT Code: 82308 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Electrophoresis | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Useful in C-cell hyperplasia, non thyroidal oat cell carcinoma, non thyroidal small cell carcinoma and other non thyroidal malignancies, acute and chronic renal failure, hypercalcemia, hypergastrinemia and other gastrointestinal disorders, and pulmonary disease. |
|
Run Day: Mon, Wed, Sat | |
Reporting Day: Next day |
Calcium, Total, Serum
Test Code: 282 | CPT Code: 82310 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Hemolysis and anticoagulants other than heparin | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Calcium measurements are useful in the diagnosis of parathyroid disease, some bone disorders and chronic renal disease. A low level of calcium may result in tetany. |
|
Run Day: Daily | |
Reporting Day: Same day |
Calprotectin, Stool
Test Code: 6890 | CPT Code: 83993 |
Specimen Type: Stool in sterile leak proof container | |
Sample Volume: 10g | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: NA | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Increases in calprotectin are seen with IBD, but also with bacterial infections, some parasitic infections, and with colorectal cancer. |
|
Run Day: Mon | |
Reporting Day: Next day |
Cancer Antigen 125
Test Code: 1143 | CPT Code: 86304 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: The CA 125 level can provide prognostic information in the follow-up management of patients with ovarian carcinoma. The assay should be used as an adjunctive test in the management of ovarian cancer patients. CA 125 is not recommended as a cancer screening procedure to detect cancer in the general population. |
|
Run Day: Sun | |
Reporting Day: Same day |
Cancer Antigen 15-3
Test Code: 1144 | CPT Code: 86300 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Grosshemolysis, and gross lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: CA 15-3 may be useful for monitoring patients with metastatic breast cancer and certain ovarian cancers. The CA 15-3 values |
|
Run Day: Sun, Tue, Thurs | |
Reporting Day: Next day |
Cancer Antigen 19-9
Test Code: 1145 | CPT Code: 86301 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: A large percentage of patients with gastrointestinal tumors (such as pancreatic, liver, gastric, colorectal tumors) and some other malignancies have been shown to have elevated serum or plasma CA 19-9 levels. The serum or plasma CA 19-9 levels may be useful for monitoring disease activity predicting relapse following treatment. CA 19-9 should not be used as a screening test. |
|
Run Day: Sun, Tue, Thurs | |
Reporting Day: Next day |
Candida Albicans, Molecular Detection
Test Code: 3638 | CPT Code: 86628 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: DNA hybridization analysis | |
Special Requirements: No special precautions needed | |
Clinical Significance: For pathogen detection |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Carbamazepine, Serum
Test Code: 1127 | CPT Code: 80156 |
Specimen Type: Serum (red-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Grosshemolysis, lipemia and icteric. Serum in gel tube (yellow-top) | |
Methodology: ECLIA | |
Special Requirements: Tubes should be centrifuged and aliquoted within 2 hours of collection. Treatment history is required. | |
Clinical Significance: Carbamazepine, an antiepileptic, is a first-line drug for treatment of partial seizures and trigeminal neuralgia. This assay is used for monitoring patients for carbamazepine therapy, toxicity and compliance |
|
Run Day: Mon, Wed, Sat | |
Reporting Day: Next day |
Carcino Embryonic Antigen (CEA)
Test Code: 1147 | CPT Code: 82378 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies involving the gastrointestinal tract, breast, lung, ovarian, prostatic, liver and pancreatic cancers. Elevated serum CEA levels have also been detected in patients with non-malignant diseases, especially patients who are older or who are smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal, and effectiveness of therapy. |
|
Run Day: Sun | |
Reporting Day: Same day |
Cardiac Profile Marker (MI Profile) (CPK,CK MB,Troponin T, LDH, SGOT)
Test Code: 6252 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays |
|
Run Day: Daily | |
Reporting Day: Same day |
Cardiac Risk Profile (Homocysteine, Apolipoprotein -A1, Apolipoprotein -B, High sensitivity C Reactive Protein (HsCRP),Total Cholesterol, Triglycerides, LDL Cholesterol, HDL Cholesterol, VLDL Cholesterol, LDL/ HDL Ratio, TC/HDL Cholesterol Ratio)
Test Code: 3609 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays |
|
Run Day: Homo- cysteine (Sat, Mon & Wed), apolipo- protein A & B (daily) | |
Reporting Day: Same day |
Carnitine, Total and Free, Serum
Test Code: 13908 | CPT Code: 82379 |
Specimen Type: Serum (red/ yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Nil | |
Methodology: Flow Injection Analysis | |
Special Requirements: No special precautions needed | |
Clinical Significance: Carnitine and its esters are required for normal energy metabolism. Evaluation of carnitine in serum is done for screening patients for suspected primary disorders of the carnitine cycle, or secondary disturbances in carnitine levels as a result of organic acidemias and fatty acid oxidation disorders. |
|
Run Day: Daily | |
Reporting Day: 15th day |
Catecholamines, Plasma
Test Code: 1133 | CPT Code: 82384 |
Specimen Type: Plasma EDTA (lavender-top (EDTA) tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: Clinical history is essential | |
Clinical Significance: The evaluation of plasma catecholamines is utilized in the differential diagnosis of pheochromocytoma. In addition, monitoring norepinephrine levels in association with clonidine suppression has been recommended as a means of distinguishing patients with pheochromocytoma from patients with essential hypertension. Measurement of plasma norepinephrine levels may aid in the differential diagnosis of orthostatic and postural hypotension. |
|
Run Day: Wed | |
Reporting Day: 2nd day |
Catecholamines, Urine
Test Code: 6842 | CPT Code: 82382 |
Specimen Type: Urine (24 hrs) in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: HPLC | |
Special Requirements: 24hrs urine with (preservative: 10 15 mL 6N HCL) & mention the total volume . Mix the sample and measure volume. Keep dark during sampling. Keep away from heat or direct sun light. Do not consume Vitamin B, coffee, bananas, alphamethydopa, MOA and COMT inhibitors as well as medication related to hypertension 72 hrs prior to the collection of the specimen. Mention clinical details (clinical history, CT scan,USG findings & medication) of the patient on the test requisition form. | |
Clinical Significance: Catecholamines include hormones epinephrine, norepinephrine and dopamine. Catecholamines, along with VMA, are produced in chromaffin cell tumors, pheochromocytoma, ganglioneuroma, and neuroblastoma. Symptoms of pheochromocytomas include episodic hypertension, headaches, sweating, heart palpitations, and anxiety. |
|
Run Day: Wed: 2nd & 4th | |
Reporting Day: 2nd day |
CBC & ESR
Test Code: 6254 | CPT Code: Use individual CPTCodes |
Specimen Type: Whole blood in a lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL (1.0 mL min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Hemolysis, sample 24 hrs old, clotted and insufficient quantity | |
Methodology: Automated/ Westergren method | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays |
|
Run Day: Daily | |
Reporting Day: Same day |
CD4+ Lymphocyte Subset (Percentage & Absolute), Blood
Test Code: 8417 | CPT Code: 86361 |
Specimen Type: EDTA whole blood (lavender-top) only. Sample to reach lab within 48 hrs | |
Sample Volume: 5 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis and gross hyperlipemic. ACD or heparinized blood, specimen in aliquot tube | |
Methodology: Flow cytometry | |
Special Requirements: Date of draw is required. | |
Clinical Significance: This assay is CD4+ lymphocyte subset enumeration using Pan Leukocyte (CD45+) Gating strategy. CD4+ lymphocyte percentages and absolute counts may be used as aid in evaluation of immune competency. Progressive clinical and immunologic deterioration correlates with decreasing CD4+ counts in HIV infections and response to therapy correlates with elevation of CD4+ counts. Reference interval of CD4+ by Pan Leucocyte gating method for persons less than 18 years is not available. |
|
Run Day: Daily | |
Reporting Day: 2nd day |
CD4+ T Cell, Immunohistochemistry
Test Code: 9871 | CPT Code: 88341 |
Specimen Type: Tissue in 10% formalin/ formalin fixed paraffin em- bedded tissue block If tissue received, it will be charged for tissue process- ing. | |
Sample Volume: 1 cm/ 1 block | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: No significant cautionary/ rejection statements. | |
Methodology: Immunohistochemistry | |
Special Requirements: Site of biopsy and clinical details mandatory. | |
Clinical Significance: CD4 is expressed on a subset of T cells (T helper cells), histiocytes, and monocytes. This test is used for histological identification of T helper cells, histiocytes, and monocytes in tissues. It can bealso used to support T cell or histiocytic lineage in hematolymphoid neoplasms. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
CD8+ T Cell, Immunohistochemistry
Test Code: 9872 | CPT Code: 88341 |
Specimen Type: Tissue in 10% formalin/ formalin fixed paraffin em- bedded tissue block If tissue received, it will be charged for tissue processing. | |
Sample Volume: 1 cm/ 1 block | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: No significant cautionary/ rejection statements. | |
Methodology: Immunohistochemistry | |
Special Requirements: Site of biopsy and clinical details mandatory. | |
Clinical Significance: This test is used for identification of cytotoxic T cells. CD8 is expressed in a subset of T cells (cytotoxic T cells). It appears on the surface of cytotoxic Tlymphocytes during intrathymic maturation and is present on approximately 20% of the T cells in the peripheral blood, lymph nodes, and spleen. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Celiac Profile (TTG IgA Antibodies, Gliadin IgG & IgA Antibodies)
Test Code: 6894 | CPT Code: 83516 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Patients with celiac disease display a hypersensitivity to gluten (wheat) in their diet. This panel helps differentiate patients with celiac disease from patients with other inflammatory bowel diseases. |
|
Run Day: Sun | |
Reporting Day: Next day |
Cervix, Cervical Punch biopsy
Test Code: 1370 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
CH 50 Complement, Total, Serum
Test Code: 6917 | CPT Code: 86162 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis, hyperlipemic | |
Methodology: Biochemical | |
Special Requirements: No special precautions needed | |
Clinical Significance: Useful in the diagnosis and management of autoimmune and renal diseases as well as in the differentiation of classical versus alternative complement pathway activation. |
|
Run Day: Daily | |
Reporting Day: 7th day |
Chikungunya Antibodies, IgM, Rapid, Serum
Test Code: 7464 | CPT Code: 86790 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ Frozen condition | |
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic | |
Methodology: Immunoconcentration | |
Special Requirements: No special precautions needed | |
Clinical Significance: Chikungunya virus (ChikV) is a single-stranded RNA alphavirus, a member of the Togaviridae family of viruses. Chikungunya IgM Rapid Test is for the qualitative detection of IgM anti-chikungunya (CHIK) virus. It is intended to be used as a screening test and provides a preliminary test result to aid in the diagnosis of infection with chikungunya virus. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Chikungunya Antibodies, IgM, Total, Serum
Test Code: 7090 | CPT Code: 86790 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoconcentration | |
Special Requirements: No special precautions needed | |
Clinical Significance: Chikungunya virus is transmitted by the bite of Aedes aegypti mosquito leading to Dengue like symptoms. However no hemorrhagic manifestations are seen. Absence of IgM Antibodies does not exclude the possibility of Chikungunya infection. |
|
Run Day: Thurs | |
Reporting Day: 3rd day |
Chlamydia DNA Detector, PCR
Test Code: 9831 | CPT Code: 87491 |
Specimen Type: Urine/ fluid/ eye swab/ genital swab (preferably BD Universal Viral Transport Swab) | |
Sample Volume: 1 mL fluid/ 1 swab/ 5-20 mL urine | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Midstream urine specimen | |
Methodology: Real Time PCR | |
Special Requirements: For urine, first portion of random voided specimen (first part of stream) to be collected | |
Clinical Significance: Chlamydia infections are caused by the obligate intracellular bacterium Chlamydia trachomatis and is one of the most prevalent sexually transmitted bacterial infection worldwide. The organism causes genitourinary infections in both genders and may be associated with dysuria and vaginal, urethral, or rectal discharge, and may lead to pelvic inflammatory disease, salpingitis, and infertility in females. |
|
Run Day: Sat, Tue | |
Reporting Day: 3rd day |
Chlamydia Trachomatis Antibodies, IgG, Serum
Test Code: 6877 | CPT Code: 86631 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: For the detection of chlamydia specific IgG antibodies |
|
Run Day: Tue | |
Reporting Day: Next day |
Chlamydia Trachomatis Antibodies, IgM, Serum
Test Code: 6878 | CPT Code: 86632 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: For the detection of chlamydia specific IgM antibodies |
|
Run Day: Tue | |
Reporting Day: Next day |
Chlamydia Trachomatis Antigen
Test Code: 344 | CPT Code: 87320 |
Specimen Type: Endocervical swabs for female & urine sample/ urethral swabs for males | |
Sample Volume: Sterile plastic shaft dry swabs and sterile urine container (10 mL) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Swab in gel tubes | |
Methodology: Immunochromatography | |
Special Requirements: No special precautions needed | |
Clinical Significance: For diagnosis of chlamydial infection. |
|
Run Day: Daily | |
Reporting Day: Next day |
Chloride, Serum
Test Code: 284 | CPT Code: 82435 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Ion Selective Electrodes (ISE) | |
Special Requirements: No special precautions needed | |
Clinical Significance: Serum chloride is the major extracellular anion and counter-balances the major cation, sodium, maintaining electrical neutrality of the body fluids. Two thirds of the total anion concentration |
|
Run Day: Daily | |
Reporting Day: Same day |
Cholesterol, Total
Test Code: 286 | CPT Code: 82465 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: Usually cholesterol is measured in a fasting sample as part of lipid profile.Ideally fasting for 9-12 hours (water only) is required. However,some physicians may ask for non-fasting cholesterl testing to study the risk factors for CVD during routine checkup. | |
Clinical Significance: Total cholesterol, in conjunction with LDL and HDL cholesterol and triglyceride determination, provide valuable information for the risk of coronary artery disease. Total serum cholesterol |
|
Run Day: Daily | |
Reporting Day: Same day |
Chromogranin A, Serum
Test Code: 6950 | CPT Code: 86316 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grosshemolysis, lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Chromogranin A is the first line test for diagnosing carcinoid tumors. It is used as a follow-up test for treated cases of carcinoid tumors. It is useful as an adjunct in the diagnosis of other neuroendocrine tumors including pheochromocytoma, pituitary adenomas and functioning & non-functioning islet cell and gastrointestinal APUD tumors. |
|
Run Day: Tue | |
Reporting Day: 2nd day |
Chromosomal Study, Product of Conception, Karyotype
Test Code: 4726 | CPT Code: 88233,88262, 88291 |
Specimen Type: Tissue | |
Sample Volume: Sterile screw-cap container tissue | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Karyotype | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Approximately 15% of all clinically recognized pregnancies are spontaneously aborted (SAB). |
|
Run Day: Sun & Thurs | |
Reporting Day: 23rd day of run |
Chromosome Analysis from Peripheral Blood
Test Code: 287 | CPT Code: 88230, 88262, 88291 |
Specimen Type: Whole blood in a green-top (heparin) tube | |
Sample Volume: 3.0mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis, specimen clotted, use of improper anticoagulant, frozen Specimen | |
Methodology: Karyotype | |
Special Requirements: Clinical information including the indication for study, detailed list of congenital abnormalities, reproductive history with known carrier status for genetic conditions. | |
Clinical Significance: This test may assist with the detection of common chromosome abnormalities. |
|
Run Day: Daily | |
Reporting Day: 14th Day |
Chromosome analysis, Additional Karyotypes, Each Study
Test Code: 4727 | CPT Code: 88280 |
Specimen Type: Whole blood (green-top tube) sodium heparin | |
Sample Volume: 5 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis, specimen clotted, use of improperanticoagulant, frozen Specimen | |
Methodology: Cell culture, karyotype, microscopy | |
Special Requirements: Clinical information including the indication for study, detailed list of congenital abnormalities, reproductive history with known carrier status for genetic conditions. | |
Clinical Significance: This test may assist with the detection of chromosome abnormalities. |
|
Run Day: Daily | |
Reporting Day: 21st day |
Chromosome Analysis, Amniotic Fluid Count 15 20 cells, 2 Karyotypes, with Banding
Test Code: 4729 | CPT Code: 88235,88269, 88280 |
Specimen Type: Amniotic fluid in 2-3 sterile centri- fuge tubes | |
Sample Volume: 20mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Frozen | |
Methodology: Cell culture, karyotype, microscopy | |
Special Requirements: Clinical history and informed consent is essential | |
Clinical Significance: Testing determines chromosomal status of the fetus. Numerical and structural chromosomal |
|
Run Day: Daily | |
Reporting Day: 18-20 days |
Chromosome analysis, In Situ for Chorionic Villus, Count Cells from 6-12 colonies, 2 Karyotypes, with Banding
Test Code: 4728 | CPT Code: 88235,88267, 88280 |
Specimen Type: Clear CVS tissue (with villi) in sterile container | |
Sample Volume: 20mg CVS sample | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Frozen | |
Methodology: Cell culture, karyotype, microscopy | |
Special Requirements: Clinical history and informed consent is essential | |
Clinical Significance: For diagnosis of chromosome abnormalities present in the fetus during the first trimester of pregnancy. |
|
Run Day: Daily | |
Reporting Day: 18-20 days |
Chronic Lymphoproliferative Disorder Panel (CD5, CD10, CD19, CD20, CD22, CD23, CD25, CD38, CD11c, CD103, FMC7, HLA DR, Surface Immunoglobulins and Light Chains)
Test Code: 13363 | CPT Code: Use individual CPTCodes |
Specimen Type: Bone marrow/ whole blood - EDTA | Bone marrow/ whole blood - heparin | Fluid - EDTA/ fluid - heparin | |
Sample Volume: 3 mL each tube | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Nil | |
Methodology: Flow Cytometry | |
Special Requirements: Bone marrow/ blood/ fluid smears must be sent. Clinical history is mandatory | |
Clinical Significance: This is a flow cytometry test that can be performed using blood, bone marrow aspirate, or body fluids. In addition to standard |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Citrate, 24 Hrs, Urine
Test Code: 13870 | CPT Code: 82507 |
Specimen Type: 24 hrs urine | |
Sample Volume: 50 mL (25mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Received room temperature | |
Methodology: Enzymatic | |
Special Requirements: 24 hrs urine sample (before starting the collection, 10 mL of 6N HCL preservative should be added to the 24 hrs urine collection container). Mention age, gender, 24 hrs urine volume and clinical details on the requisition form. | |
Clinical Significance: Urinary citrate is a major inhibitor of kidney stone formation due to it binding of calcium in urine. |
|
Run Day: Wed, Sat | |
Reporting Day: 3rd day |
CK MB (POCT)
Test Code: 5787 | CPT Code: 82553 |
Specimen Type: Heparinized venous/ whole blood in a green- top (heparin) tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Serum collected in a yellow-top tube, plasma | |
Methodology: POCT | |
Special Requirements: No special precautions needed | |
Clinical Significance: Elevated Levels of CKMB occurs 4 to 6 hrs after the onset of pain in mycocardial infarction, peak at 18 to 24 hrs and persist upto 72 hrs. |
|
Run Day: Daily | |
Reporting Day: Same day |
CK MB, Serum
Test Code: 288 | CPT Code: 82552 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Hemolysis and received thawed | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Elevated levels of CKMB occurs 4 to 6 hrs after the onset of pain in myocardial infarction, peak at 18 to 24 hrs and persist upto 72 hrs. |
|
Run Day: Daily | |
Reporting Day: Same day |
Clostridium Difficile, Stool
Test Code: 7139 | CPT Code: 87324 |
Specimen Type: Stool in sterile leak proof container | |
Sample Volume: 1.0 gm | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: NA | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Clostridium difficile is a bacterial pathogen that causes pseudomembranous colitis andantibiotic associated diarrhoea. It produces toxins A & B which are enterotoxins. A positive result is considered presumptive evidence of Clostridium difficile infection |
|
Run Day: Sat & Wed | |
Reporting Day: 11th day |
Clotting Time (CT)
Test Code: 443 | CPT Code: 85670 |
Specimen Type: Conducted on patient | |
Sample Volume: Done on patient | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Ivy method | |
Special Requirements: Only walking patients | |
Clinical Significance: Screening for bleeding tendency. |
|
Run Day: Daily | |
Reporting Day: Same day |
CMV Antibodies, IgG, Serum
Test Code: 345 | CPT Code: 86644 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Exposure to cytomegalovirus (CMV) occurs throughout life and by adulthood, 50 90% of the population is seropositive for CMV antibodies. CMV is spread by close contact, sexual transmission, perinatal or congenital transmission, and through blood transfusions and tissue trans- |
|
Run Day: Sat, Tue, Thurs | |
Reporting Day: Same day |
CMV Antibodies, IgM, Serum
Test Code: 346 | CPT Code: 86645 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Intrauterine or congenital CMV infections occur in 0.5 to 2.2% of all live births. Symptomatic congenital infections usually occur in infants born to nonim- |
|
Run Day: Sat, Tue, Thurs | |
Reporting Day: Same day |
CMV, Viral Load, Real Time PCR
Test Code: 17240 | CPT Code: 87497 |
Specimen Type: EDTA Plasma / EDTA Whole Blood (lavender-top) | |
Sample Volume: 5.0 mL (3.0mL - min) | |
Transport Condition: EDTA plasma: Room temperature/ refrigerated/frozen, EDTA whole blood: Room temperature/ refrigerated | |
Specimen Rejection Criteria: Nil | |
Methodology: Real Time PCR | |
Special Requirements: Clinical history is required | |
Clinical Significance: Cytomegalovirus (CMV) is a common and major cause of opportunistic infection in organ transplant recipients, causing significant morbidity and mortality. |
|
Run Day: Tue, Thurs, Sat | |
Reporting Day: 6th day |
Coagulation Profile {PT, PTT, Platelet Count (Automated), Fibrinogen, D Dimer}
Test Code: 1182 | CPT Code: Use individual CPTCodes |
Specimen Type: Citrated plasma in blue top (Sodium Citrate) tube, whole blood in lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL in each tube | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Do not thaw | |
Methodology: See individual assays | |
Special Requirements: No special precautions needed | |
Clinical Significance: See individual assays |
|
Run Day: Daily | |
Reporting Day: Next day |
Complement C1q, Immunoflourescence
Test Code: 15927 | CPT Code: 86160 |
Specimen Type: | |
Sample Volume: 1 cm | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Nil | |
Methodology: Immunoflourescence | |
Special Requirements: Clinical history and site of biopsy are mandatory | |
Clinical Significance: This assay is used for detection of complement C1q in kidney, and skin biopsy specimens by immunofluorescence. |
|
Run Day: Daily | |
Reporting Day: 7th day |
Complement C3, Serum
Test Code: 6164 | CPT Code: 86160 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis, hyperlipemic | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Decreased C3 may be associated with acute glomerulonephritis, membranoproliferative glomerulonephritis, immune complex disease, active systemic lupus erythematosus, and generalized autoimmune processes. |
|
Run Day: Daily | |
Reporting Day: 5th day |
Complement C4, Serum
Test Code: 6163 | CPT Code: 86160 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis, hyperlipemic | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Decreased C4c level is associated with acute systemic lupus erythematosus, glomerulonephritis, immune complex disease, cryoglobulinemia, congenital C4c deficiency and generalized autoimmune diseases. |
|
Run Day: Daily | |
Reporting Day: 5th day |
Complement Protein Concentration (C3), Serum
Test Code: 6855 | CPT Code: 86160 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis, hyperlipemic | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Decreased C3 may be associated with acute glomerulonephritis, membranoproliferative glomerulonephritis, immune complex disease, active systemic lupus erythematosus, and generalized autoimmune processes. |
|
Run Day: Daily | |
Reporting Day: 5th day |
Complement Protein concentration (C4), Serum
Test Code: 6856 | CPT Code: 86160 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis, hyperlipemic | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Decreased C4c level is associated with acute systemic lupus erythematosus, glomerulonephritis, immune complex disease, cryoglobulinemia, congenital C4c deficiency and generalized autoimmune diseases. |
|
Run Day: Daily | |
Reporting Day: 5th day |
Complement, Total, Serum
Test Code: 1306 | CPT Code: 86162 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 1.0 mL (0.5mL) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Nephelometry | |
Special Requirements: Age & gender of the patient is mandatory for reporting | |
Clinical Significance: These analytes are useful in the diagnosis and management of autoimmune and renal diseases as well as in the differentiation of classical versus alternative complement pathway activation. |
|
Run Day: Daily | |
Reporting Day: 6th day |
Complete Blood Count (CBC){automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count}
Test Code: 1543 | CPT Code: 85025 |
Specimen Type: Whole blood in a lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Grosshemolysis and clotted | |
Methodology: Cell Counter | |
Special Requirements: No special precautions needed | |
Clinical Significance: Enumeration of the components in the blood to provide a general hematologic assessment. |
|
Run Day: Daily | |
Reporting Day: Same day |
Complete Blood Count (CBC){automated (Hgb, Hct, RBC, WBC and platelet count)}
Test Code: 4739 | CPT Code: 85027 |
Specimen Type: Whole blood in a lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL (1.0 mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Grosshemolysis and clotted | |
Methodology: Cell Counter | |
Special Requirements: No special precautions needed | |
Clinical Significance: Enumeration of the components in the blood and to provide a general hematologic assessment. |
|
Run Day: Daily | |
Reporting Day: Same day |
Complete Thyroid Profile (T3, T4, TSH, FT3, FT4)
Test Code: 6255 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: For diagnosis of hypothyroidism and hyperthyroidism. |
|
Run Day: Daily | |
Reporting Day: Same day |
Conjunctival Biopsy
Test Code: 1353 | CPT Code: 88304 |
Specimen Type: Tissue | |
Sample Volume: formalin-fixed, paraffin-embedded tissue block | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopic | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 3rd day |
Copper, 24 Hrs, Urine
Test Code: 8424 | CPT Code: 82525 |
Specimen Type: 24 hrs urine | |
Sample Volume: 10 -20 mL(5mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Improperly collectected sample | |
Methodology: GFAAS with Zeeman correction | |
Special Requirements: 24 hrs urine in metal free jerry can available from the lab (no preservative). 24 hrs volume should be invariably specified. Shake the can and take the 10-20 ml aliquot in metal free scintillation vial or sterile urine culture container, both available from the lab (no preservative). The measurement of urine volume should be done after aliquoting. | |
Clinical Significance: Urine copper excretion is increased in Wilson disease due to a decreased serum binding of copper to ceruloplasmin, or |
|
Run Day: Wed, Sat | |
Reporting Day: 2nd day |
Cortisol, Free, 24 Hrs, Urine
Test Code: 6914 | CPT Code: 82530 |
Specimen Type: Urine -24 hrs | |
Sample Volume: 10.0 mL aliquot(Specify 24 hrs volume on test request form) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: NA | |
Methodology: ECLIA | |
Special Requirements: 24 hrs urine specimen to be collected without preservative. Clinical history required | |
Clinical Significance: This assay is preferred as a screening test for Cushing syndrome. It also helps in the diagnosis of pseudo hyperaldosteronism due to excessive licorice consumption. The test has limited usefulness in the evaluation of adrenal insufficiency. |
|
Run Day: Sat, Mon, Wed | |
Reporting Day: Same day |
Cortisol, Random, Urine
Test Code: 1263 | CPT Code: 82530 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: ECLIA | |
Special Requirements: No special precautions needed | |
Clinical Significance: This assay is preferred as a screening test for Cushing syndrome. It also helps in the diagnosis of pseudo hyperladosteronism due to excessive licorice consumption. The test has limited usefulness in the evaluation of adrenal insufficiency. |
|
Run Day: Sun, Wed | |
Reporting Day: Next day |
Cortisol, Total, Serum
Test Code: 468 | CPT Code: 82533 |
Specimen Type: Serum collected in a red-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis and gross icteric | |
Methodology: Immunoassay | |
Special Requirements: | |
Clinical Significance: Total serum cortisol is useful in the assessment of adrenal |
|
Run Day: Sun, Wed | |
Reporting Day: Same day |
Coxasackie Antibodies, IgG, Serum
Test Code: 6872 | CPT Code: 86658 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: For detection of antibodies to Coxasackie infection |
|
Run Day: Thurs | |
Reporting Day: 15th day |
Coxasackie Antibodies, IgM, Serum
Test Code: 6873 | CPT Code: 86658 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: For detection of Antibodies to Coxasackie infection |
|
Run Day: Thurs | |
Reporting Day: 15th day |
CPK (Creatine Phosphokinase), Serum
Test Code: 281 | CPT Code: 82550 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Test for myocardial infarction and skeletal muscle damage. Elevated results may be due to myocarditis, myocardial infarction, muscular dystrophy, muscle trauma or excessive exercise. |
|
Run Day: Daily | |
Reporting Day: Same day |
Creatinine Clearance, Endogenous
Test Code: 1170 | CPT Code: 82575 |
Specimen Type: Serum collected in a yellow-top tube24hrs. Urine in sterile leak proof container | |
Sample Volume: 3.0 mL serum and 10 mL 24 hrs urine | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry / calculation | |
Special Requirements: 24 hrs urine with (preservative: 10 15 mL 6N HCL) & mention the total volume. Mix the sample and measure volume. Keep in dark during sampling. Keep away from heat or direct sun light. | |
Clinical Significance: To monitor kidney function |
|
Run Day: Daily | |
Reporting Day: Same day |
Creatinine, Serum
Test Code: 290 | CPT Code: 82565 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Hemolysis and plasma | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Serum creatinine is useful in the evaluation of kidney function and in monitoring renal dialysis. A serum creatinine result within the reference range does not rule out function impairment: serum creatinine is not sensitive to |
|
Run Day: Daily | |
Reporting Day: Same day |
Creatinine, Urine
Test Code: 291 | CPT Code: 82570 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: To monitor kidney function |
|
Run Day: Daily | |
Reporting Day: Same day |
Cryoglobulin, Qualitative, Serum
Test Code: 16473 | CPT Code: 82595 |
Specimen Type: Serum (red-top tube) | |
Sample Volume: 3.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Serum in gel tube (yellow-top). Specimen volume less than 3 mL | |
Methodology: Inspection, Physical (Heating) | |
Special Requirements: Tube must remain at 37 degrees C. Allow blood to clot at 37 degrees C. | |
Clinical Significance: Cryoglobulins are immunoglobulins that precipitate when cooled and dissolve when heated.Cryoglobulins may be associated with diseases like plasma cell disorders, autoimmune diseases, and infections. This assay aids |
|
Run Day: Daily | |
Reporting Day: Next day |
CSF Analysis, Routine
Test Code: 1271 | CPT Code: 89051 |
Specimen Type: CSF in sterile container | |
Sample Volume: 3 mL, two tubes and label the order of collection. | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Traumatic tap. | |
Methodology: Microscopy / Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Assess CNS infections |
|
Run Day: Daily | |
Reporting Day: Same day |
Culture, Bone Marrow
Test Code: 403 | CPT Code: 87070 |
Specimen Type: Bone marrow | |
Sample Volume: Bone marrow in sterile leak proof container | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Specimen unsterile, leaked container, frozen specimen | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Bone marrow culture results may aid in the diagnosis of systemic fungal & bacterial infections. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Cervical Swab for Gonorrhea
Test Code: 7150 | CPT Code: 87070 |
Specimen Type: Cervical swab | |
Sample Volume: One or two swabs in sterile swab tube/container | |
Transport Condition: Room temperature/suitable transport medium | |
Specimen Rejection Criteria: Expired transport device, frozen or dry swabs | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Gonorrhea is a genderually transmitted disease (STD) that can infect both men and women.It can cause infections in the genitals, rectum, and throat. It is a very common infection, especially among young people aged 15-24 years. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, CSF
Test Code: 404 | CPT Code: 87070 |
Specimen Type: CSF in sterile container | |
Sample Volume: Cerebrospinal fluid in sterile leak-proof container | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Cereberospinal fluid cultures are of importance in the diagnosis of bacterial meningitis. The most common causes of thislife threatening condition are E.coli and Group B streptococci in neonates, H. influenzae (2 months5 years), N. meningitidis (all ages, most common in older |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Fungi
Test Code: 407 | CPT Code: 87102 |
Specimen Type: Sputum, urine in sterile leak proof container, stool, fluids, CSF, swab, pus, semen, other than blood | |
Sample Volume: Sufficient quantity | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Non-viable and frozen isolates | |
Methodology: Culture | |
Special Requirements: Clinical history is essential | |
Clinical Significance: The clinical significance of an isolate vaires with the identification, source, and clinical symptoms manifested. |
|
Run Day: Daily | |
Reporting Day: Preliminary report : 1st week & 2nd week. Final report: 1 Month |
Culture, Nasopharyngeal Swab
Test Code: 408 | CPT Code: 87070 |
Specimen Type: Nasopharyngeal (NP), nasal passages and paranasal sinus drainage | |
Sample Volume: Culture swab in transport device, sample in sterile leak proof tube | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Expired transport device, frozen specimens | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Culture of the nose (as opposed to nasopharynx) is primarily for the detection of Staphylococcus aureus. The significance of other organisms is difficult to assess since this site and its discharges can easily be colonized by a variety of organisms. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Pus/ Wound/ Burns
Test Code: 409 | CPT Code: 87070 |
Specimen Type: Pus / wound swab / burn swab | |
Sample Volume: Sample in sterile swab or leak proof container | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Expired transport device, frozen specimens | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: On identification of the organism, antibiotic susceptibilities are performed that aid in selectionof appropriate antibiotic for treatment. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Semen
Test Code: 410 | CPT Code: 87070 |
Specimen Type: Semen | |
Sample Volume: Sterile leak-proof container | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: sample in unsterile condition | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: For pathogen detection |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Sputum
Test Code: 1283 | CPT Code: 87070 |
Specimen Type: Sputum | |
Sample Volume: Sterile leak-proof container | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Leaked container | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Isolation of potential respiratory pathogens can be useful in the diagnosis of respiratory tract infection. Since respiratory specimens contain organisms found in normal flora, evaluate isolates accordingly. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Stool
Test Code: 411 | CPT Code: 87045 |
Specimen Type: Stool | |
Sample Volume: In a sterile sample container atleaset 5 gm of feces required. Rectal swabs is also accept- able. | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Frozen specimens, Specimen in diaper or parasitology transport vial | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: Salmonella and shigella are considered pathogens when isloated from clinical specimens.Identification of these oraganisms is important for treatment and infection control. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Culture, Urine
Test Code: 412 | CPT Code: 87086 |
Specimen Type: Clean catch mid- stream urine in sterile leak proof container | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Specimen unsterile, leaked container, frozen specimen | |
Methodology: Culture & sensitivity | |
Special Requirements: Clinical history is essential | |
Clinical Significance: This culture is designed to quantitate the growth of significant bacteria when collected by the clean catch guidelines or from indwelling catheters. Quantitative culturing of urine is an established tool to differentiate significant bacteruria from contamination introduced during voiding. This test has a reference range of less than 1,000 bacteria per mL. More than 95% of urinary tract infections (UTI) are attributed to a single organism.Infecting organisms are usually present at greater that 100,000 per mL, but a lower density may be clinically important. In cases of UTI where more than one organism is present, the predominant organism is usually significant and others are probably urethral or collection contaminants. When multiple organisms are isolated from patients with indwelling catheters, UTI is doubtful and colonization likely. |
|
Run Day: Daily | |
Reporting Day: 4th day |
Cyclosporine A, Blood
Test Code: 6152 | CPT Code: 80158 |
Specimen Type: Whole blood in lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Grosshemolysis/ clot | |
Methodology: Immunoassay | |
Special Requirements: Sample is typically drawn 12 hours after the last dose of the drug.In the morning when you are scheduled to have cyclosporine level checked, do not take the medicine until after the blood is drawn | |
Clinical Significance: Cyclosporine is an immunosuppressant therapeutic agent used in the prevention of organ graft rejection. Measurement of blood levels is recommended due to the inter-individual variability of metabolism as well as the toxicity associated with excessive dosage. |
|
Run Day: Tue, Thurs, Sat | |
Reporting Day: 4th day |
Cystatin C, Serum
Test Code: 1308 | CPT Code: 82610 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 1.0 mL (0.5mL) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Nephelometry | |
Special Requirements: 10 -12 hrs fasting & clinical history (age & gender) are mandatory | |
Clinical Significance: Sensitive marker for chronic kidney disease. |
|
Run Day: Mon, Wed, Fri | |
Reporting Day: Next day |
Cystic Fibrosis Screening
Test Code: 7451 | CPT Code: 81220 |
Specimen Type: Dry blood spot | |
Sample Volume: Spot on filter paper | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: NA | |
Methodology: Time resolved fluoremetry technique (Immunoassay) | |
Special Requirements: Sample should be collected when baby is 22-72 hour old. Sample should be collected from heel of baby. Blood to be soaked front and back of circle of filter card. | |
Clinical Significance: Also known as mucoviscidosis, cystic fibrosis is a genetic disorder that affects mostly the lungs but also the pancreas, liver,kidneys and intestine. This is a screening test of cystic fibrosis disease. |
|
Run Day: Sun, Tue, Thurs | |
Reporting Day: 3rd day |
Cystine, Random/ 24 hrs, Urine
Test Code: 6879 | CPT Code: 82615 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Received room temperature, received refrigerated, received thawed and pH<2.0 | |
Methodology: Spectrophotometry | |
Special Requirements: | |
Clinical Significance: Cystinuria is an autosomal recessive disease in which dibasic amino acid, including cystine, are excreted in excess. |
|
Run Day: Tue: 2nd, 4th | |
Reporting Day: 5th day |
Cytomegalo Virus DNA Detector, PCR
Test Code: 9833 | CPT Code: 87497 |
Specimen Type: Whole blood/ Plasma (lavender-top EDTA tube), Serum (yellow-top tube) or CSF | |
Sample Volume: 3 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Green-top (heparin) tube, ACD plasma | |
Methodology: PCR | |
Special Requirements: Nil | |
Clinical Significance: Cytomegalovirus (CMV) is a common and major cause of opportunistic infection in organ transplant recipients, causing significant morbidity and mortality.Lung, heart, small intestine, pancreas, and kidney-pancreas transplant recipients are at greater risk for CMV infection than kidney and liver transplant recipients. |
|
Run Day: Sat, Tue | |
Reporting Day: 3rd day |